Publications by authors named "Emir Deljkich"
Article Synopsis
- The STAIR XII workshop focused on improving neuroimaging techniques for diagnosing acute ischemic stroke, bringing together experts from academia, industry, and government to identify key priorities.
- Ten critical areas were outlined for advancements, including enhancing imaging at stroke centers, refining clot analysis, and establishing criteria to predict treatment response.
- Despite progress in imaging for stroke treatment, significant challenges persist, highlighting the need for collaboration among academics, industry, and regulators to enhance technologies and improve patient outcomes.
The Stroke Treatment Academic Industry Roundtable XII included a workshop to discuss the most promising approaches to improve outcome from acute stroke. The workshop brought together representatives from academia, industry, and government representatives. The discussion examined approaches in 4 epochs: pre-reperfusion, reperfusion, post-reperfusion, and access to acute stroke interventions.
View Article and Find Full Text PDFThe Stroke Treatment Academic Industry Roundtable (STAIR) convened a session and workshop regarding enrollment in acute stroke trials during the STAIR XII meeting on March 22, 2023. This forum brought together stroke physicians and researchers, members of the National Institute of Neurological Disorders and Stroke, industry representatives, and members of the US Food and Drug Administration to discuss the current status and opportunities for improving enrollment in acute stroke trials. The workshop identified the most relevant issues impacting enrollment in acute stroke trials and addressed potential action items for each.
View Article and Find Full Text PDFBackground: A single non-invasive gene expression profiling (GEP) test (AlloMap®) is often used to discriminate if a heart transplant recipient is at a low risk of acute cellular rejection at time of testing. In a randomized trial, use of the test (a GEP score from 0-40) has been shown to be non-inferior to a routine endomyocardial biopsy for surveillance after heart transplantation in selected low-risk patients with respect to clinical outcomes. Recently, it was suggested that the within-patient variability of consecutive GEP scores may be used to independently predict future clinical events; however, future studies were recommended.
View Article and Find Full Text PDFThe effects of transoral incisionless fundoplication on chronic GERD patients: 12-month prospective multicenter experience.
Surg Laparosc Endosc Percutan Tech
February 2014
Article Synopsis
- * No major complications were found, with significant reductions in the need for proton pump inhibitors and improvements in symptoms like heartburn and regurgitation among patients.
- * Overall, TIF was concluded to be a safe and effective treatment option for selected patients suffering from chronic GERD.
Background: A retrospective community-based study evaluated the safety and symptomatic outcomes of the transoral incisionless fundoplication (TIF) procedure with or without hiatal hernia repair (HHR) in patients with chronic gastroesophageal reflux disease (GERD).
Materials And Methods: Forty-eight patients underwent TIF using EsophyX (EndoGastric Solutions, Redmond, WA) in 3 community hospitals. Patients who presented with a hiatal hernia 3 cm or more in the greatest transverse diameter underwent laparoscopic HHR before TIF.
Background: A retrospective study evaluated safety, symptom resolution, patient satisfaction, and medication use 1-2 years after transoral incisionless fundoplication (TIF) in patients with gastroesophageal reflux disease (GERD) and/or laryngopharyngeal reflux (LPR) symptoms.
Methods: Thirty-four patients with a confirmed diagnosis of GERD symptoms that were inadequately controlled by antisecretory medications, and who where either dissatisfied with their current therapy or not willing to continue taking medication, underwent TIF using EsophyX at our community-based hospital. Follow-up assessments were completed in 28 patients.